4//SEC Filing
MOTT RICHARD W 4
Accession 0001209191-23-023543
CIK 0001630627other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 9:00 PM ET
Size
6.9 KB
Accession
0001209191-23-023543
Insider Transaction Report
Form 4
MOTT RICHARD W
Director
Transactions
- Sale
Common Stock
2023-04-04$26.00/sh−15,756$409,667→ 909,043 total - Sale
Common Stock
2023-04-03$26.00/sh−201$5,226→ 924,799 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]Includes 2,295 RSUs.
- [F3]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.0000 to $25.9050 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
TREACE MEDICAL CONCEPTS, INC.
CIK 0001630627
Entity typeother
Related Parties
1- filerCIK 0001210226
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 9:00 PM ET
- Size
- 6.9 KB